These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32927237)

  • 41. Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.
    Puvanesarajah S; Gapstur SM; Patel AV; Sherman ME; Flanders WD; Gansler T; Troester MA; Gaudet MM
    Breast Cancer Res Treat; 2019 Oct; 177(3):679-689. PubMed ID: 31264062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
    Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
    Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive predictive values by mammographic density and screening mode in the Norwegian Breast Cancer Screening Program.
    Moshina N; Ursin G; Roman M; Sebuødegård S; Hofvind S
    Eur J Radiol; 2016 Jan; 85(1):248-254. PubMed ID: 26724673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts.
    Chae EY; Kim HH; Cha JH; Shin HJ; Kim H
    J Ultrasound Med; 2013 Sep; 32(9):1573-8. PubMed ID: 23980217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT.
    Wang H; Bjurstam N; Bjørndal H; Braaten A; Eriksen L; Skaane P; Vitak B; Hofvind S; Thoresen SØ
    Int J Cancer; 2001 Nov; 94(4):594-8. PubMed ID: 11745450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection Rate, Recall Rate, and Positive Predictive Value of Digital Compared to Screen-Film Mammography in the Quebec Population-Based Breast Cancer Screening Program.
    Théberge I; Vandal N; Langlois A; Pelletier É; Brisson J
    Can Assoc Radiol J; 2016 Nov; 67(4):330-338. PubMed ID: 27451910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.
    José Bento M; Gonçalves G; Aguiar A; Antunes L; Veloso V; Rodrigues V
    J Med Screen; 2014 Jun; 21(2):104-9. PubMed ID: 24803482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The financial impact of a breast cancer detected within and outside of screening: lessons from the Australian Lifepool cohort.
    Saxby K; Nickson C; Mann GB; Velentzis L; Bromley HL; Procopio P; Canfell K; Petrie D
    Aust N Z J Public Health; 2020 Jun; 44(3):219-226. PubMed ID: 32311194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
    Otten JD; Karssemeijer N; Hendriks JH; Groenewoud JH; Fracheboud J; Verbeek AL; de Koning HJ; Holland R
    J Natl Cancer Inst; 2005 May; 97(10):748-54. PubMed ID: 15900044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
    Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
    Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study.
    Tsuruda KM; Hoff SR; Akslen LA; Hofvind S
    Br J Cancer; 2024 Jan; 130(1):99-107. PubMed ID: 38049556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
    Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
    Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Number of prior negative screening outcomes does not influence future risk of breast cancer.
    Lilleborge M; Falk RS; Hofvind S
    Eur J Epidemiol; 2020 Jun; 35(6):549-556. PubMed ID: 32430839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.